Metformin to Mitigate Sequelae of Radioactive Iodine Treatment for Thyroid Cancers
Clinical trial NCT03109847 · TERMINATED
Trial details
- NCT number
- NCT03109847
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-05
- Primary completion
- 2020-12-29
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.